Irritable Bowel Syndrome (IBS) is a collection of unpleasant symptoms associated with the digestive system which affects approximately 10 million people in the UK. IBS is considered to be an uncomfortable yet non-life threatening condition, and has been identified as a trigger for many other more serious conditions.
In this week’s article we provide a roundup of some of the most recent health and nutrition related articles to be in the news, five items comprising:
- Kids devouring too much ‘breakfast sugar’ warning
- Olive oil could slash your chances of bone fractures in half, study says
- Autism may begin early in brain development
- The appendix may have an important function, new research suggests
- Air pollution may lead to dementia in older women
Getting bogged down in the detail of functional tests? You’re not the only one. With a greater number of functional and genetic tests out there, some provided by reputable labs, some by lesser known, more “novel” outfits, this is a subject that is now at the forefront of the minds of most health practitioners.
In this week’s blog, experienced functional practitioner Miguel Toribio-Mateas shares with us how clinical applicability is the key to choosing the appropriate test, and how to do that to optimise clinical outcomes. Miguel discusses his top 5 considerations that he believes all functional practitioners should take into account before choosing the right test for their clients.
It’s that time of year again! Everyone’s talking about which diet they’re going on and what exercise they’re going to do in order to get to their goal weight but, when it comes to obesity, is it really as simple as calories in/energy out?
Our blog this week has been written by Debi-Ann Wrigglesworth, a nutritional therapist with a Masters Degree from the University of Worcester. Debi-Ann looks at how obesity is the most common form of disruption in energy balance, and is a major, and very prevalent, disorder of nutrition.
In November last year, new figures from the Office for National Statistics showed that dementia is now the leading cause of death in England and Wales, replacing ischaemic heart disease. It is the leading cause for women and overall, heart disease remains the leading cause for men.
There isn’t a week that passes where Alzheimer’s or dementia is not in the news – a new drug offers hope, a new drug has failed, a well loved celebrity has the disease, a therapy has shown promise. Nevertheless, although over 244 drugs have been approved for dementia, they have failed to make any real, lasting difference, other than perhaps some short term symptom improvement.
“The science of gene-diet interaction is one of the most promising strategies we have in order to improve general health”, a quotation from Professor Giovanni Scapagnini taken from this week’s blog, in which clinical neuroscientist and functional nutrition practitioner Miguel Toribio-Mateas interviews Professor Scapagnini on the complex subject of nutrigenetics and its role in disease prevention and treatment.